MMRGlobal eHealth Investor Sales Update

LOS ANGELES, CA--(Marketwire - Apr 13, 2012) - MMRGlobal, Inc. (OTCBB: MMRF) ("MMR") today recapped a full week of news that may not have been available to shareholders due to an inadvertent omission, the result of a formatting error, of the Item 9A information required in the Company's 2011 Annual Report on Form 10-K, which was timely filed with the Securities and Exchange Commission on March 30, 2012. This temporarily affected the Company's trading symbol for those interested in following eHealth, Personal Health Records (PHRs) and OTCBB: MMRF. "So in case you missed any of the Company's news this past week," said Bob Lorsch, MMRGlobal Chairman & CEO, "Take out your highlighter and read about all the exciting things that went on at MMR."

On April 9^th, MMRGlobal announced an agreement with VIDA Senior Resource, Inc. to launch a private-branded MyMedicalRecords PHR to 50,000 patients in VIDA's nationwide organization of certified owned and operated home care services agencies (http://phx.corporate-ir.net/phoenix.zhtml?c=178404&p=irol-newsArticle&ID=1681008&highlight). On April 10, MMRGlobal released a story on how the Company, with joint venture partner Unis-Tonghe Technology (Zhengzhou) Co., Ltd., will work with Alcatel-Lucent in China to launch its MyMedicalRecords Personal Health Record in 10 selected hospitals in China's Henan Province (http://phx.corporate-ir.net/phoenix.zhtml?c=178404&p=irol-newsArticle&ID=1681385&highlight); and on April 12, MMR issued a release that it would be to selling its Personal Health Record products and services at the Visiting Nurses Associations of America Annual Meeting May 2-4 in Phoenix (http://phx.corporate-ir.net/phoenix.zhtml?c=178404&p=irol-newsArticle&ID=1682378&highlight).

MMRGlobal is a leading provider of Personal Health Records, MyEsafeDepositBox storage solutions and electronic document management and imaging systems for healthcare professionals. During the past year, MMRGlobal has launched strategic relationships with UST Global®, 4medica, Interbit Data, Alcatel-Lucent and the ng Connect Program, as well as internationally with licensee VisiInc PLC in Australia and strategic partner Unis-Tonghe in China. These relationships represent the development of efforts to attach the Company's patented technologies used in its flagship MyMedicalRecords Personal Health Record and MMRPro systems to any Electronic Medical Records platform, as well as receive lab, pharmacy and telemedicine system information.

A copy of the earnings release issued by MMRGlobal on March 29, 2012 and the Company's Annual Report on Form 10-K filed with the SEC on March 30, 2012 are available at www.mmrglobal.com in the Investor Relations section and also at www.sec.gov.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of the Company's products and services at www.mmrtheater.com.

Forward-Looking Statements

All statements in this press release that are not strictly historical in nature, including future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Actual results and the timing of selected events may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. Such statements are subject to various risks and uncertainties, including but not limited to those discussed or incorporated by reference herein. Factors that could cause or contribute to such differences include, but are not limited to, the risk the Company's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition, including variations in our quarterly and year-end operating results; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; litigation matters; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product and service introductions; ability to establish and maintain strategic relationships; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; maintaining, developing and defending our intellectual property rights; marketing and exploitation of our patent portfolio both in the U.S. and internationally; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. The Company is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.